Has Everett Grahn received payments from drug or device companies?

Yes. Drug and device makers reported $8,978 in general payments to Everett Grahn across 409 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Everett Grahn did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Everett Grahn come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Everett Grahn

Hematology & Oncology · Orange, CANPI 1477593770

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.8% of the total across 409 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 45 manufacturers, the largest accounting for just 9.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $6,750 and has fallen 96.5% since, to $238 in 2023.

$8,978in general payments, 2019–2025

Across 409 payments — averaging $21.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$864
Genentech USA, Inc.$851
E.r. Squibb & Sons, L.L.C.$781
Eisai Inc.$759
Pharmacyclics LLC, An Abbvie Company$604
Merck$594
plus $5K from 39 others

What the payments were for

Speaking & faculty fees$1352%
Food & beverage$8,78098%
Education$641%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	27	$864
Genentech USA, Inc.	40	$851
E.r. Squibb & Sons, L.L.C.	46	$781
Eisai Inc.	20	$759
Pharmacyclics LLC, An Abbvie Company	37	$604
Merck	24	$594
Novartis	25	$559
Amgen	23	$500
Johnson & Johnson(2 entities)	10	$323
Seagen Inc.	15	$318
Exelixis Inc.	9	$306
Sanofi	12	$286
Pfizer	25	$252
AbbVie	11	$192
Puma Biotechnology, Inc.	4	$174
Aurobindo Pharma USA, Inc.	1	$168
Bayer	5	$124
EMD Serono, Inc.	7	$109
Tersera Therapeutics LLC	4	$107
Takeda Pharmaceuticals U.S.A., Inc.	5	$106
Regeneron Healthcare Solutions, Inc.	2	$103
Astellas Pharma US Inc	4	$82
Foundation Medicine, Inc.	4	$70
Lexicon Pharmaceuticals, Inc.	4	$70
Dova Pharmaceuticals	4	$66
Bristol Myers Squibb	4	$65
AMAG Pharmaceuticals, Inc.	3	$64
Gilead	4	$58
Daiichi Sankyo Inc.	3	$54
Clovis Oncology, Inc.	3	$45
CSL Behring	3	$41
Boehringer Ingelheim	3	$39
Sun Pharmaceutical Industries Inc.	1	$33
Tesaro, Inc.	2	$30
Teva Pharmaceuticals USA, Inc.	2	$28
Taiho Oncology, Inc.	2	$26
Lilly USA, LLC	1	$20
Spectrum Pharmaceuticals Inc.	1	$18
Ipsen Biopharmaceuticals, Inc	1	$17
Helsinn Therapeutics (U.S.), Inc.	1	$15
Incyte Corporation	1	$14
EUSA Pharma (US) LLC	1	$13
Karyopharm Therapeutics Inc.	1	$13
Secura Bio, Inc.	3	$10
Sanofi-aventis U.S. LLC	1	$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,978 in reported general payments places this provider in the 65th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California →

Other hematology & oncology in Orange

Catherine CoombsOrange$786K
Arash Rezazadeh KalebastyOrange$516K
Misako NagasakaOrange$507K
Elizabeth BremOrange$335K
May ChoOrange$334K
Angela FleischmanOrange$255K
Dennis SlamonLos Angeles$3.1M
Sandra HorningStanford$2.5M
Mohammadbagher ZiariCorona$2.5M
George YaghmourLos Angeles$1.9M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →